DaShenLin Pharmaceutical Group. (603233.SHG) Q4 2025 Earnings

30OctConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
0.18
0.25
0.33
0.4

Details

Expected EPS
0.17918908946579398
Actual EPS
0.2496073035
Surprise EPS
0.07
Surprise Percent
+39.3%

Description

DaShenLin Pharmaceutical Group. (603233.SHG) has reported earnings of 0.2496073035 per share for Q4 2025.

0 Comments

Share your thoughts